NCT03886610

Brief Summary

The overall study aim is to provide additional magnetic resonance imaging parameters of the cervical spinal cord, brainstem and brain and a better understanding of changes after spinal cord injury (SCI) and to define new magnetic resonance (MR) biomarkers to correlate with sensomotoric functioning and clinical outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 22, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

March 27, 2019

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 13, 2023

Status Verified

March 1, 2023

Enrollment Period

3.8 years

First QC Date

March 21, 2019

Last Update Submit

March 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Fractional Anisotropy (FA)

    Degree of anisotropy of a diffusion process (value between zero and one). A value of zero means that diffusion is isotropic, i.e. it is unrestricted (or equally restricted) in all directions. A value of one means that diffusion occurs only along one axis and is fully restricted along all other directions. FA is a measure often used in diffusion imaging where it is thought to reflect fiber density, axonal diameter, and myelination in white matter.

    16-40 days after injury, 70-96 days after injury, 150- 186 days after injury

Secondary Outcomes (2)

  • Change in Apparent Diffusion Coefficient (ADC)

    16-40 days after injury, 70-96 days after injury, 150- 186 days after injury

  • Change in Relative Anisotropy (RA)

    16-40 days after injury, 70-96 days after injury, 150- 186 days after injury

Study Arms (3)

Healthy controls

Individuals without spinal cord injury

Other: Healthy controls

Subacute SCI patients

Subacute patients with spinal cord injury (duration \>2 weeks)

Other: Subacute SCI patients

Chronic SCI patients

Patients with chronic spinal cord injury (duration ≥24 months)

Other: Chronic SCI patients

Interventions

individuals without spinal cord injury

Healthy controls

individuals with spinal cord injury ≥ 2 weeks

Subacute SCI patients

individuals with spinal cord injury ≥ 24 months

Chronic SCI patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* 20 healthy controls * 35 patients with subacute spinal cord injury * 20 patients with chronic spinal injury

You may qualify if:

  • age between 18 and 80 years
  • no previous history of severe cervical trauma, traumatic brain injury, cervical surgery or signs of neurological impairment and no known neurological disease.

You may not qualify if:

  • not meeting the MRI screening requirements
  • unable to give consent
  • Subacute and chronic patients with spinal cord injury:
  • lesion level at or below C3
  • etiology of the spinal cord injury is traumatic or non-traumatic
  • age between 18 and 80 years
  • time of trauma or onset of symptoms for subacute SCI patients is more than 3 weeks and for the chronic SCI patients more than 2 years
  • lesion level below L2
  • other known pathology of the spinal cord/brain (e.g. MS) or progressive neurological disorders
  • inability to meet the MRI screening requirements (e.g. pacemaker or other electronic devices),
  • severe head trauma as defined by a Glasgow Coma Scale (GCS) of \< 14
  • patients who are ventilator dependant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Swiss Paraplegic Centre

Nottwil, 6207, Switzerland

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Ernst Christiaanse, MD

    Swiss Paraplegic Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Radiologist

Study Record Dates

First Submitted

March 21, 2019

First Posted

March 22, 2019

Study Start

March 27, 2019

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

March 13, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations